Latest

Jul 28, 2026, 09:38 C. Vijayakumar Is Betting HCLTech’s Engineering DNA on Owning More of the AI Stack

Jul 27, 2026, 18:19 Hans Patuwo Has Taken GoTo Into Profit. The Harder Test Is Making It Durable

Jul 26, 2026, 21:15 Shanghai Medical School Investigates Undisclosed Death in Gene-Therapy Trial

Jul 26, 2026, 21:14 Japan Logs Fifth Straight ‘Cruelly Hot Day’ as Heat Risks Escalate

Jul 26, 2026, 20:41 Formula One Returns to Malaysia as Sepang Hosts Rescheduled Bahrain Grand Prix

Jul 26, 2026, 13:00 Teochew Film Dear You Turns Chaoshan Villages Into Heritage Destinations

Jul 26, 2026, 13:00 Typhoon Noul Weakens After Disrupting Hong Kong and Southern China

Jul 26, 2026, 12:59 China Fines Trip.com 5.18 Billion Yuan Over Monopoly Abuses

dengue

An Aedes aegypti mosquito, the primary vector for dengue, photographed in West Bengal, India; source: Wikimedia Commons

India Clears Takeda’s QDENGA, Opening a New Test of Dengue Prevention

India’s regulator has authorized Takeda’s two-dose QDENGA vaccine for people aged four to 60, creating a new prevention option in one of the countries most exposed to dengue.